. Earth Science News .
EPIDEMICS
Zimbabwe lacks AIDS drugs to expand treatment: official

by Staff Writers
Harare (AFP) July 11, 2010
Zimbabwe may not have enough anti-AIDS drugs to comply with World Health Organisation recommendations on providing treatment to people with HIV, a top health official said Sunday.

Zimbabwe is currently treating about 200,000 people whose immune systems have been severely weakened by the disease, but the WHO recommends that treatment should start earlier.

"The number of people in need of treatment will double if we follow the World Health Organisation plan," Tsitsi Mutasa Apollo, co-ordinator of HIV treatment in the health ministry, said in the state-run Sunday Mail.

"We are likely to experience more drug shortages," said Apollo.

The new guidelines would mean about 500,000 people need treatment, the paper said.

Zimbabwe's prevention and treatment campaign relies on donor funding, after a near decade of economic crisis also which crippled health services.

The country imposes an AIDS levy on workers to fund drug procurement for over 1.6 million people living with the virus.

Last year HIV infected 13.7 percent of adults, down from a high of 33 percent in 1999.

The decline has been attributed to donor-backed prevention campaigns which promotes safe sex and discourages multiple sexual partners.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Breakthrough antibodies neutralize most known AIDS strains
Washington (AFP) July 8, 2010
US researchers have discovered two powerful antibodies that neutralize more than 90 percent of all known strains of the HIV virus in the lab, new research released Thursday showed. NIH-led scientists discovered the antibodies known as VRCO1 and VRCO2 that prevent most HIV strains from infecting human cells. The find is a potential breakthrough for advancing HIV vaccine design, and antibody t ... read more







EPIDEMICS
Six months after quake, Haitians frustrated by aid trickle

New BP cap, ships could capture all leaking oil: US

China to begin major quake reconstruction effort

US government launches new website on Gulf oil spill

EPIDEMICS
Facebook deal means virtual 'credits' can be bought in shops

Wake up, check Facebook

Apple to issue patch for iPhone 4 antenna woes

Apple hit with lawsuit over iPhone 4 antenna woes

EPIDEMICS
US, Indonesian scientists journey to bottom of sea

Ethiopia seeks to reassure Egypt over Nile waters

Cleaner Water Mitigates Climate Change Effects On Florida Keys Coral Reefs

La Nina likely to develop in coming months: UN weather body

EPIDEMICS
Arctic Climate May Be More Sensitive To Warming Than Thought

US scientist in race to learn from Indonesia's dying glacier

China sets sail for the Arctic

Answer To What Ended The Last Ice Age May Be Blowing In The Winds

EPIDEMICS
China seizes melamine-tainted milk powder: reports

China's AgBank offers room for improvement

Across the US, employer-sponsored gardens grow

Drought destroys millions of hectares of Russian crops: govt

EPIDEMICS
Mexican sisters survive floods after four days in tree

WWF presses Romania for long-term flood measures

5.4 earthquake rattles southern California: USGS

Tropical depression forms in Gulf of Mexico

EPIDEMICS
Northrop Grumman Wins African Training Contract

G. Bissau president warns army top brass, drug traffickers

Religious intolerance threatens Nigerian democracy: Jonathan

Chinese-built hospital risks collapse in Angola: state radio

EPIDEMICS
Timor-Leste warms to Australia asylum idea

U.S. government challenges Ariz. law

Tibetan Adaptation To Altitude Took Less Than 3,000 Years

A Butterfly Effect In The Brain


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement